WO2006083950A3 - Method for reducing the level of peroxides in bopcompatible polymer preparations - Google Patents
Method for reducing the level of peroxides in bopcompatible polymer preparations Download PDFInfo
- Publication number
- WO2006083950A3 WO2006083950A3 PCT/US2006/003524 US2006003524W WO2006083950A3 WO 2006083950 A3 WO2006083950 A3 WO 2006083950A3 US 2006003524 W US2006003524 W US 2006003524W WO 2006083950 A3 WO2006083950 A3 WO 2006083950A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peroxides
- level
- bopcompatible
- reducing
- polymer preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Abstract
The present invention is related to materials and methods for forming polymeric delivery vehicles that reduces risk of oxidative degradation of a carried drug and the resulting compositions. A method is described to reduce the level of peroxides in biocompatble polymer preparations .
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65025205P | 2005-02-03 | 2005-02-03 | |
US60/650,252 | 2005-02-03 | ||
US11/183,477 US8496943B2 (en) | 2003-03-31 | 2005-07-18 | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
US11/183,477 | 2005-07-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006083950A2 WO2006083950A2 (en) | 2006-08-10 |
WO2006083950A3 true WO2006083950A3 (en) | 2006-11-23 |
Family
ID=36694246
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/003524 WO2006083950A2 (en) | 2005-02-03 | 2006-02-01 | Method for reducing the level of peroxides in bopcompatible polymer preparations |
PCT/US2006/003858 WO2006084140A2 (en) | 2005-02-03 | 2006-02-03 | Method for reducing the level of peroxides in bopcompatible polymer preparations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/003858 WO2006084140A2 (en) | 2005-02-03 | 2006-02-03 | Method for reducing the level of peroxides in bopcompatible polymer preparations |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1843747A2 (en) |
AR (1) | AR054221A1 (en) |
AU (1) | AU2006210560A1 (en) |
CA (1) | CA2596860A1 (en) |
NO (1) | NO20074476L (en) |
WO (2) | WO2006083950A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
CN103841556A (en) * | 2014-03-21 | 2014-06-04 | 北京航空航天大学 | Method for rapid switching of wireless local area networks |
CN115666621A (en) | 2020-01-13 | 2023-01-31 | 度勒科特公司 | Sustained release drug delivery systems with reduced impurities and related methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089335A2 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
-
2006
- 2006-02-01 WO PCT/US2006/003524 patent/WO2006083950A2/en active Application Filing
- 2006-02-03 CA CA002596860A patent/CA2596860A1/en not_active Abandoned
- 2006-02-03 EP EP06720234A patent/EP1843747A2/en not_active Withdrawn
- 2006-02-03 WO PCT/US2006/003858 patent/WO2006084140A2/en active Application Filing
- 2006-02-03 AR AR20060100405A patent/AR054221A1/en unknown
- 2006-02-03 AU AU2006210560A patent/AU2006210560A1/en not_active Abandoned
-
2007
- 2007-09-03 NO NO20074476A patent/NO20074476L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089335A2 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
US20050008661A1 (en) * | 2003-03-31 | 2005-01-13 | Fereira Pamela J. | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
US20050276856A1 (en) * | 2003-03-31 | 2005-12-15 | Fereira Pamela J | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
Also Published As
Publication number | Publication date |
---|---|
NO20074476L (en) | 2007-11-02 |
AU2006210560A1 (en) | 2006-08-10 |
EP1843747A2 (en) | 2007-10-17 |
WO2006084140A2 (en) | 2006-08-10 |
WO2006083950A2 (en) | 2006-08-10 |
WO2006084140B1 (en) | 2007-03-15 |
CA2596860A1 (en) | 2006-08-10 |
WO2006084140A3 (en) | 2007-01-11 |
AR054221A1 (en) | 2007-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006125082A3 (en) | Hydrogels and hydrogel particles | |
WO2009081169A3 (en) | Biodegradable contrast agents | |
EP1486195A3 (en) | Personal product compositions comprising structured benefit agent pre-mix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent | |
WO2006107903A3 (en) | Polymeric micelles for drug delivery | |
WO2006052968A3 (en) | Stabilized ramipril compositions and methods of making | |
WO2007076371A3 (en) | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
WO2006108009A3 (en) | Controlled degradation materials for therapeutic agent delivery | |
WO2005084637A3 (en) | Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof | |
WO2006047409A3 (en) | Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds | |
WO2006071613A3 (en) | Injectable non-aqueous suspension | |
WO2008034124A3 (en) | Targeted polymeric prodrugs containing multifunctional linkers | |
WO2005089805A3 (en) | Polymer-based compositions and conjugates of hiv entry inhibitors | |
WO2006071693A3 (en) | Injectable non-aqueous suspension | |
WO2007140312A3 (en) | Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations | |
WO2006083991A3 (en) | Fiber-reinforced composite absorbable endoureteral stent | |
WO2006039704A3 (en) | Pharmaceutical composition and method for treating a joint capsule arthropathy | |
WO2006060815A3 (en) | Fibrous structures comprising a nanoparticle additive | |
WO2007038246A3 (en) | Solid polymer delivery compositions and methods for use thereof | |
WO2007147010A3 (en) | Implantable medical devices and methods for making the same | |
WO2008131451A3 (en) | Pva-paa hydrogels | |
WO2006121522A3 (en) | Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions | |
WO2008010991A3 (en) | Methods and compositions for the treatment of cancer | |
WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
WO2010033726A3 (en) | Drug delivery composition comprising a self-assembled gelator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06720059 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06720059 Country of ref document: EP Kind code of ref document: A2 |